Featured Stories

New wrinkle treatment, Juvederm Vollure XC, shows lasting results

Brought to you by Dr. Mark Petroff, Petroff Center Plastic Surgery & Medi-Spa - COSMETIC SURGERY INSIDER -

PETROFF CENTER - Dr. Mark PetroffIs it time to freshen up your face by smoothing out the "parenthesis" lines that often appear after many years of smiling?

If you're frowning because of the folds and wrinkles that form under your cheeks (from your nostrils toward your mouth), there's a brand-new injectable product that can help.

The U.S. Food and Drug Administration (FDA) recently approved Juvederm Vollure XC for injection into facial tissue to correct moderate to severe facial wrinkles and folds in adults. Juvederm Vollure XC was just made available in the U.S. in April.

As with other injectable beauty treatments, don't trust an amateur.

Dr. Mark Petroff has a deep understanding of facial structure and proportion, applying an artist's touch to get the best result.

In the U.S. clinical trial, 59 percent of Vollure XC patients saw improvement in moderate to severe nasolabial folds for up to 18 months. Eighty-two percent of patients said they were very satisfied at 6 months and 68 percent at 18 months.


Juvederm Vollure XC is formulated with proprietary Vycross technology, which blends different molecular weights of hyaluronic acid, contributing to the gel's duration.

What's exciting about Juvederm Vollure XC is that it was shown to last up to 18 months from the initial or touch-up injection in a majority of subjects, the longest-lasting result shown in a clinical study in the nasolabial folds.

Call Petroff Center for a consultation to see whether Juvederm Vollure XC is right for you!

Petroff Center Plastic Surgery & Medi-Spa

17720 Jean Way, Ste. 100

Lake Oswego, OR 97035